长城证券股份有限公司关于 浙江泰林生物技术股份有限公司 长城证券股份有限公司（以下简称"长城证券"或"保荐机构"）作为浙江泰林 生物技术股份有限公司（以下简称"泰林生物"或"公司"）首次公开发行股票并上 市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作（2025 年修订）》等有关规定，对公司 2025 年半年度募 集资金存放与使用情况进行了核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准浙江泰林生物技术股份有限公司首次 公开发行股票的批复》（证监许可〔2019〕2962 号）核准，并经深圳证券交易 所同意，本公司由主承销商安信证券股份有限公司采用余额包销方式，向社会公 众公开发行人民币普通股（A 股）股票 1,300.00 万股，发行价为每股人民币 18.35 元，共计募集资金 23,855.00 万元，坐扣承销和保荐费用 2,545.00 万元后的募集 资金为 21,310.00 万元，已由主承销商安信证券股份有限公司于 ...

张 阳： 招商证券股份有限公司 募集资金承诺 调整后投资总 截至期末累计 资进度 预定可 使 本年度实现 达到 性是否发 和超募资金投 项目（含部 本期投入金额 投资总额 额（1） 投入金额(2) （%）(3)＝ 用状态日 的效益 预计 生重大变 向 分变更） (2)/(1) 期 效 益 化 年产 12000km 未 达 无机绝缘及年 到 预 无 268,360,000.00 268,360,000.00 127,090.00 265,079,147.85 98.78 - 18,569,621.05 否 产 600km 油井 计 效 加热电缆项目 益 补充流动资金 不 适 无 200,000,000.00 200,000,000.00 - 200,000,000.00 100.00 不适用 不适用 否 项目 用 超募资金永久 不 适 无 - 39,732,734.07 - 35,730,000.00 89.93 不适用 不适用 否 补充流动资金 用 承诺投资项目 - 468,360,000.00 508,092,734.07 127,090.00 500,809,147.85 98.57 - - - - 小计 ...

股票代码：601233 股票简称：桐昆股份 公告编号：2025-048 桐昆集团股份有限公司 第九届董事会第十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 桐昆集团股份有限公司（以下简称"桐昆股份"或"公司"）第 九届董事会第十九次会议通知于2025年8月17日以书面或邮件、电话 等方式发出，会议于2025年8月27日在桐昆股份总部会议室以现场结 合通讯表决的方式召开。会议应到董事十一名,实到董事十一名。会 议由董事长陈蕾女士主持，本次会议的召开符合《中华人民共和国公 司法》《公司章程》及有关法律、法规的规定。经过有效表决，会议 一致通过如下决议： 三、审议并通过《关于 <募集资金半年度存放与使用情况的专项> 报告>的议案》。 根据《上市公司募集资金监管规则》和上海证券交易所印发的 《上海证券交易所上市公司自律监管指引第 1 号——规范运作（2023 年 12 月修订）》（〔2023〕193 号）的规定，公司编制了《桐昆集 团股份有限公司关于募集资金半年度存放与使用情况的专项报告》， 并经董事会审议通过。 ...

Core Points - The company held its 13th meeting of the 4th Board of Directors on August 27, 2025, with all 7 directors present, complying with relevant laws and regulations [1][2]. Group 1: Meeting Resolutions - The board approved the 2025 semi-annual report and summary with a unanimous vote of 7 in favor [2]. - The board approved a special report on the storage and actual use of raised funds for the first half of 2025, also with a unanimous vote of 7 in favor [2]. - The board approved an adjustment to the repurchase price of the sixth phase of the restricted stock incentive plan and the repurchase and cancellation of certain restricted stocks, with a unanimous vote of 7 in favor [3]. - The board approved a proposal for a subsidiary to apply for listing on the New Third Board, with 6 votes in favor, 0 against, 0 abstentions, and 1 abstention due to conflict of interest [3][4]. - The board approved the establishment of a special account for raised funds and the signing of a regulatory agreement, with a unanimous vote of 7 in favor [4]. - The board approved the appointment of a new financial director, with a unanimous vote of 7 in favor [4]. - The board approved amendments to the Articles of Association and related governance documents, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved the election of a non-independent director, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved amendments to the Independent Director System, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved amendments to the External Investment Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the External Guarantee Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Related Party Transaction Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Internal Control System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Fund Management Measures, with a unanimous vote of 7 in favor, pending shareholder approval [8]. - The board approved a proposal to convene the third extraordinary general meeting of shareholders in 2025, with a unanimous vote of 7 in favor [8].

一、监事会会议召开情况： 上海泰坦科技股份有限公司（以下简称"公司"）第四届监事会第十八次会 议通知已于 2025 年 8 月 17 日以书面方式送达全体监事，会议于 2025 年 8 月 27 日以现场结合通讯方式召开，本次会议由监事会主席顾梁先生召集并主持，应到 监事 3 人，实到监事 3 人。本次会议的召集和召开符合《中华人民共和国公司法》 和《上海泰坦科技股份有限公司章程》（以下简称《公司章程》）等相关规定， 会议形成的决议合法、有效。 证券代码：688133 证券简称：泰坦科技 公告编号：2025-035 上海泰坦科技股份有限公司 第四届监事会第十八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、监事会会议审议情况： 公司监事会认为公司 2025 年半年度募集资金存放与实际使用情况符合《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》、公司《募集资金管理制度》等法律法规和制度文件 的规定，对募集资金进行了专户存储和专项使用，并及时履行了 ...

（安徽） 基地项目 补充流 动 不适 不适 否 400,000,000.00 400,000,000.00 400,000,000.00 - 400,912,344.51 912,344.51 100.23 不适 用 否 资 金 用 用 超募资 金 不适 不适 否 360,253,498.97 360,253,498.97 360,253,498.97 83,778,451.82 191,778,451.82 -168,475,047.15 不适用 不适 用 不适用 净 额 用 用 合计 — 1,266,253,498.97 1,266,253,498.97 1,266,253,498.97 116,781,932.01 685,050,523.09 -581,202,975.88 — — — — 未达到计划进度原因（分具体募投项目） 不适 用 项目可行性发生重大变化的情况说明 不适用 募集资金投资项目先期投入及置换情况 不适用 用闲置募集资金暂时补充流动资金情况 不适用 对闲置募集资金进行现金管理，投资相关产品情况 见本报告"三、募集资金的实际使用情况之 （四）对闲置募集资金进行现金管理，投资相关产品情况" ...

证券代码：688605 证券简称：先锋精科 公告编号：2025-028 江苏先锋精密科技股份有限公司 告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》 （证 监会公告〔2025〕10号）、《上海证券交易所科创板上市公司自律监 管指引第1号——规范运作》以及《上海证券交易所科创板股票上市 规则》的相关规定，江苏先锋精密科技股份有限公司（以下简称"公 司"或"本公司"）董事会编制了2025年半年度（以下简称"报告期" ） 募集资金存放、管理与实际使用情况的专项报告如下： 一、募集资金基本情况 （一）实际募集资金金额及资金到位情况 经中国证券监督管理委员会《关于同意江苏先锋精密科技股份有 限公司首次公开发行股票注册的批复》（证监许可[2024]1325 号）核 准，并经上海证券交易所同意，本公司由主承销商华泰联合证券有限 责任公司（以下简称"华泰联合"）2024 年 11 月 29 日向社会公众 首次公开发行人民币普通股（A 股）50,595,000 股（面值人民币 1 元 ...

证券代码：603596 证券简称：伯特利 公告编号：2025-070 芜湖伯特利汽车安全系统股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集资 金管理和使用的监管要求》和上海证券交易所《上海证券交易所上市公司自律监管 指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指南第 1 号——公 告格式》等相关规定，将芜湖伯特利汽车安全系统股份有限公司（以下简称本公司 或公司）2025 年半年度募集资金存放与使用情况报告如下： 一、 募集资金基本情况 （一）实际募集资金金额及资金到账时间 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准芜湖伯特 利汽车安全系 统股份有限公司公开发行 可转换公司债券的批复》（证监许可 [2020]3389 号）核准，同意公司向社会公开发行面值总额人民币 90,200 万元可转换 公司债券（以下简称"可转债"），期限 6 年。2021 年 6 月 29 日，公司实际公开 发行可转债 902 万张，每张 ...

Core Viewpoint - The company establishes a comprehensive system for managing and utilizing raised funds to enhance efficiency and ensure compliance with relevant laws and regulations [1][2][3]. Fund Management - The company must continuously monitor the storage, management, and usage of raised funds to prevent investment risks and ensure effective implementation of the system [1][2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and safeguarding their security [1][2]. Fund Storage - Raised funds should be stored in a dedicated account approved by the board of directors, and must not be used for non-raising purposes [2][3]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received [2][3]. Fund Usage - The company is required to use raised funds according to the usage plan outlined in the issuance application documents [3][4]. - If there are significant changes affecting the feasibility or expected returns of the investment projects, the company must reassess and disclose the situation [4][5]. Cash Management - The company may manage temporarily idle raised funds through cash management, ensuring that it does not affect the normal progress of investment projects [5][6]. - Cash management products must be safe, liquid, and not exceed a twelve-month term [6][7]. Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board of directors and disclosed to shareholders [9][10]. - The company must provide a detailed explanation for any changes in investment projects, including reasons and expected impacts [11][12]. Reporting and Supervision - The company must disclose the actual usage of raised funds accurately and completely, and report any significant deviations from the investment plan [24][25]. - The sponsor or independent financial advisor is responsible for ongoing supervision and must report any irregularities to the relevant regulatory authorities [26][27].

Core Viewpoint - The company has completed the fundraising project from its initial public offering (IPO) and plans to permanently supplement its working capital with the remaining funds, which aligns with regulatory requirements and does not harm the interests of shareholders, especially minority shareholders [1][7]. Fundraising Overview - The company raised a total of 380.5252 million yuan from the IPO by issuing 21.67 million shares at a price of 17.56 yuan per share, with a net amount of 343.4518 million yuan after deducting issuance costs of 37.0734 million yuan [1][2]. - The funds were stored in a dedicated account, and a tripartite supervision agreement was signed with the sponsor and the bank [1]. Investment Project Details - The total investment for the initial fundraising projects was 466.2129 million yuan, with the company planning to use 343.4518 million yuan from the raised funds [2]. - The original project for "three-layer solid wood composite flooring construction" was changed to "Shanghai Filinger Wood Industry Co., Ltd. renovation and expansion project," with a total investment of 150 million yuan [2][3]. - Subsequent adjustments included adding a three-layer solid wood composite flooring production line to the renovation and expansion project [3]. Project Timeline and Adjustments - The completion timeline for the renovation and expansion project and the enterprise information technology construction project has been extended multiple times, with the latest deadline set for August 2025 [5][6]. Fund Usage and Surplus - As of June 30, 2025, the company had a total of 343.4518 million yuan in raised funds, with 104.8785 million yuan cumulatively invested, resulting in a surplus of 271.9114 million yuan [5]. - The surplus funds will be used to permanently supplement working capital, enhancing operational efficiency and reducing financial costs [6]. Regulatory Compliance and Approval - The company has followed the necessary procedures for the approval of the fundraising project conclusion and the use of surplus funds, ensuring compliance with relevant regulations [7].